Kathryn Kolibaba, MD

Articles by Kathryn Kolibaba, MD

Dr. Kolibaba on Efficacy of Entospletinib in Mantle Cell Lymphoma

January 4th 2017

Kathryn Kolibaba, MD, co-chair, Hematology Research Committee, US Oncology Research, discusses why the Syk inhibitor entospletinib demonstrates efficacy in patients with mantle cell lymphoma (MCL).

Dr. Kolibaba on Mechanism of Action With Entospletinib in MCL

ByKathryn Kolibaba, MD

December 23rd 2016

Kathryn Kolibaba, MD, co-chair, Hematology Research Committee, US Oncology Research, discusses the mechanism of action with entospletinib (GS-9973) and its potential as a treatment for patients with mantle cell lymphoma (MCL).

Dr. Kolibaba on Entospletinib Activity in Mantle Cell Lymphoma

ByKathryn Kolibaba, MD

December 21st 2016

Kathryn Kolibaba, MD, co-chair, Hematology Research Committee, US Oncology Research, discusses a study of entospletinib in the treatment of patients with mantle cell lymphoma.